Vista do USE OF INFLAMMATORY AND MOLECULAR BIOMARKERS IN THE EARLY DIAGNOSTIC ASSESSMENT OF SEPSIS IN CRITICALLY ILL PATIENTS: LIMITS, ADVANCES, AND CLINICAL PERSPECTIVES

Voltar aos Detalhes do Artigo USE OF INFLAMMATORY AND MOLECULAR BIOMARKERS IN THE EARLY DIAGNOSTIC ASSESSMENT OF SEPSIS IN CRITICALLY ILL PATIENTS: LIMITS, ADVANCES, AND CLINICAL PERSPECTIVES Baixar Baixar PDF